CD8A and breast carcinoma: We demonstrated previously that intratumorally delivery of MDA-7 (by means of a replication-incompetent Ad.5-mda-7) stimulated systemic antigen-specific CD8+ T cell responses in breast cancer (14), supporting an immunological contribution of MDA-7 in mediating breast cancer killing.